Study 2: the study of medical records

GG Giovanni de Girolamo
OA Ole A. Andreassen
MB Michael Bauer
PB Paolo Brambilla
SC Stefano Calza
NC Nicholas Citerà
RC Rosa Corcoy
AF Andrea Fagiolini
MG Miguel Garcia-Argibay
OG Ophélia Godin
FK Florian Klingler
NK Nene F. Kobayashi
HL Henrik Larsson
ML Marion Leboyer
SM Silke Matura
AM Alessandra Martinelli
VP Víctor De la Peña-Arteaga
RP Roberto Poli
AR Andreas Reif
PR Philipp Ritter
LR Linn N. Rødevand
MM Marta Magno
EC Elisa Caselani
ask Ask a question
Favorite

Considering a confidence level of 95% and a standard error of 5%, the study would require the inclusion of at least 385 patients to provide a valid representation of the population under investigation. However, our study takes on an additional layer of complexity as we aim to make a cross-country comparison, analysing differences within the study population. To accomplish this and maintain robust statistical power, we need to consider a power level of 0.9 and an alpha level of 0.05. These choices are essential to ensure that our study is adequately powered to detect any meaningful differences between the countries being examined. Given these criteria and assuming an effect strength (η2) of 0.015, we should aim to include a minimum of 346 patient records from each site, thus totalling 1,730 patient records for the four countries comparative analysis (France, Germany, Italy, Norway, and Spain). This larger sample size is necessary to account for the population differences and to draw meaningful conclusions about the healthcare conditions and outcomes in each country.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A